MedTrace Logo

A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body

NCT06655220 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-03-05

No results posted yet for this study

Summary

The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 1815368 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).

Conditions

  • Healthy

Interventions

DRUG

Metformin hydrochloride

Metformin hydrochloride

DRUG

BI 1815368

BI 1815368

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-08
Primary Completion
2024-12-08
Completion
2025-01-13

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06655220 on ClinicalTrials.gov